SLC5A2 and diabetes mellitus: Their successful development has provided a new approach for the treatment of diabetes and has become a research hotspot for hypoglycemic drugs.[32,33] SGLT-2 is the primary transporter responsible for the reabsorption of glucose filtered by renal tubules.